Contribution of type III interferons to antiviral immunity: Location, location, location

Journal of Biological Chemistry

Volumn 292, Issue 18, 2017, Pages 7295-7303

  Kotenko, Sergei V ^a,b,c   Durbin, Joan E ^a,b,c  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b Rutgers The State University of New Jersey   (United States)

^c University of Medicine and Dentistry of New Jersey   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTICS; GLYCOPROTEINS; VIRUSES;

ADAPTIVE IMMUNE RESPONSE; ANTI-MICROBIAL PROTECTION; COLLATERAL DAMAGE; CROSS REGULATION; MULTIPLE LEVELS; NOVEL LIGANDS; TYPE I INTERFERONS; VIRUS INFECTION;

LOCATION;

ALPHA INTERFERON; INTERFERON; INTERFERON RECEPTOR; INTERLEUKIN 29; LAMBDA INTERFERON; LAMBDA INTERFERON RECEPTOR; UNCLASSIFIED DRUG; IL29 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE;

ANTIVIRAL ACTIVITY; ASTHMA; CHRONIC HEPATITIS C; CYTOKINE PRODUCTION; HEPATITIS C VIRUS; HUMAN; IMMUNOCOMPETENT CELL; INFLUENZA A; NONHUMAN; NOROVIRUS INFECTION; PROTEIN EXPRESSION; REOVIRIDAE; REVIEW; RHEUMATOID ARTHRITIS; ROTAVIRUS; SIGNAL TRANSDUCTION; VIRUS IMMUNITY; ADAPTIVE IMMUNITY; ANIMAL; IMMUNOLOGY; INNATE IMMUNITY; VIRUS INFECTION;

ADAPTIVE IMMUNITY; ANIMALS; HUMANS; IMMUNITY, INNATE; INTERFERON TYPE I; INTERLEUKINS; VIRUS DISEASES;

EID: 85018378564     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.R117.777102     Document Type: Review

References (101)

1. Krause, C. D., and Pestka, S. (2015) Cut, copy, move, delete: the study of human interferon genes reveals multiple mechanisms underlying their evolution in amniotes. Cytokine 76, 480-495
2. Qi, Z., Nie, P., Secombes, C. J., and Zou, J. (2010) Intron-containing type I and type III IFN coexist in amphibians: refuting the concept that a retroposition event gave rise to type I IFNs. J. Immunol. 184, 5038-5046
3. Sang, Y., Liu, Q., Lee, J., Ma, W., McVey, D. S., and Blecha, F. (2016) Expansion of amphibian intronless interferons revises the paradigm for interferon evolution and functional diversity. Sci. Rep. 6, 29072
4. Boudinot, P., Langevin, C., Secombes, C. J., and Levraud, J. P. (2016) The peculiar characteristics of fish type I interferons. Viruses 8, E298
5. Kotenko, S. V., and Langer, J. A. (2004) Full house: 12 receptors for 27 cytokines. Int. Immunopharmacol. 4, 593-608
6. Kotenko, S. V. (2002) The family of IL-10-related cytokines and their receptors: related, but to what extent? Cytokine Growth Factor Rev. 13, 223-240
7. Langer, J. A., Cutrone, E. C., and Kotenko, S. (2004) The class II cytokine receptor (CRF2) family: overview and patterns of receptor-ligand interactions. Cytokine Growth Factor Rev. 15, 33-48
8. Aggad, D., Mazel, M., Boudinot, P., Mogensen, K. E., Hamming, O. J., Hartmann, R., Kotenko, S., Herbomel, P., Lutfalla, G., and Levraud, J. P. (2009) The two groups of zebrafish virus-induced interferons signal via distinct receptors with specific and shared chains. J. Immunol. 183, 3924-3931
9. Isaacs, A., and Lindenmann, J. (1957) Virus interference: 1. The interferon. Proc. R. Soc. Lond. B Biol. Sci. 147, 258-267
10. Kotenko, S. V., Gallagher, G., Baurin, V. V., Lewis-Antes, A., Shen, M., Shah, N. K., Langer, J. A., Sheikh, F., Dickensheets, H., and Donnelly, R. P. (2003) IFN-λs mediate antiviral protection through a distinct class II cytokine receptor complex. Nat. Immunol. 4, 69-77
11. Sheppard, P., Kindsvogel, W., Xu, W., Henderson, K., Schlutsmeyer, S., Whitmore, T. E., Kuestner, R., Garrigues, U., Birks, C., Roraback, J., Ostrander, C., Dong, D., Shin, J., Presnell, S., Fox, B., et al. (2003) IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat. Immunol. 4, 63-68
12. Prokunina-Olsson, L., Muchmore, B., Tang, W., Pfeiffer, R. M., Park, H., Dickensheets, H., Hergott, D., Porter-Gill, P., Mumy, A., Kohaar, I., Chen, S., Brand, N., Tarway, M., Liu, L., Sheikh, F., et al. (2013) A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus. Nat. Genet. 45, 164-171
13. Lasfar, A., Lewis-Antes, A., Smirnov, S. V., Anantha, S., Abushahba, W., Tian, B., Reuhl, K., Dickensheets, H., Sheikh, F., Donnelly, R. P., Raveche, E., and Kotenko, S. V. (2006) Characterization of the mouse IFN-λ ligand-receptor system: IFN-λs exhibit antitumor activity against B16 melanoma. Cancer Res. 66, 4468-4477
14. Witte, K., Gruetz, G., Volk, H. D., Looman, A. C., Asadullah, K., Sterry, W., Sabat, R., and Wolk, K. (2009) Despite IFN-λ receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokines. Genes Immun. 10, 702-714
15. Huang, J., Smirnov, S. V., Lewis-Antes, A., Balan, M., Li, W., Tang, S., Silke, G. V., Pütz, M. M., Smith, G. L., and Kotenko, S. V. (2007) Inhibition of type I and type III interferons by a secreted glycoprotein from Yaba-like disease virus. Proc. Natl. Acad. Sci. U.S.A. 104, 9822-9827
16. Kotenko, S. V. (2011) IFN-λs. Curr. Opin. Immunol. 23, 583-590
17. Lee, S. J., Kim, W. J., and Moon, S. K. (2012) Role of the p38 MAPK signaling pathway in mediating interleukin-28A-induced migration of UMUC-3 cells. Int. J. Mol. Med. 30, 945-952
18. Odendall, C., Dixit, E., Stavru, F., Bierne, H., Franz, K. M., Durbin, A. F., Boulant, S., Gehrke, L., Cossart, P., and Kagan, J. C. (2014) Diverse intracellular pathogens activate type III interferon expression from peroxisomes. Nat. Immunol. 15, 717-726
19. Dumoutier, L., Lejeune, D., Hor, S., Fickenscher, H., and Renauld, J. C. (2003) Cloning of a new type II cytokine receptor activating signal transducer and activator of transcription (STAT)1, STAT2 and STAT3. Biochem. J. 370, 391-396
20. Kotenko, S. V., Izotova, L. S., Pollack, B. P., Muthukumaran, G., Paukku, K., Silvennoinen, O., Ihle, J. N., and Pestka, S. (1996) Other kinases can substitute for Jak2 in signal transduction by interferon-γ. J. Biol. Chem. 271, 17174-17182
21. Kotenko, S. V., Krause, C. D., Izotova, L. S., Pollack, B. P., Wu, W., and Pestka, S. (1997) Identification and functional characterization of a second chain of the interleukin-10 receptor complex. EMBO J. 16, 5894-5903
22. Marcello, T., Grakoui, A., Barba-Spaeth, G., Machlin, E. S., Kotenko, S. V., MacDonald, M. R., and Rice, C. M. (2006) Interferons α and λ inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics. Gastroenterology 131, 1887-1898
23. Bolen, C. R., Ding, S., Robek, M. D., and Kleinstein, S. H. (2014) Dynamic expression profiling of type I and type III interferon-stimulated hepatocytes reveals a stable hierarchy of gene expression. Hepatology 59, 1262-1272
24. Jilg, N., Lin, W., Hong, J., Schaefer, E. A., Wolski, D., Meixong, J., Goto, K., Brisac, C., Chusri, P., Fusco, D. N., Chevaliez, S., Luther, J., Kumthip, K., Urban, T. J., Peng, L. F., et al. (2014) Kinetic differences in the induction of interferon stimulated genes by interferon-α and interleukin 28B are altered by infection with hepatitis C virus. Hepatology 59, 1250-1261
25. Malakhova, O. A., Kim, K. I., Luo, J. K., Zou, W., Kumar, K. G., Fuchs, S. Y., Shuai, K., and Zhang, D. E. (2006) UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity. EMBO J. 25, 2358-2367
26. François-Newton, V., Magno de Freitas Almeida, G., Payelle-Brogard, B., Monneron, D., Pichard-Garcia, L., Piehler, J., Pellegrini, S., and Uzé, G. (2011) USP18-based negative feedback control is induced by type I and type III interferons and specifically inactivates interferon α response. PLoS ONE 6, e22200
27. Burkart, C., Arimoto, K., Tang, T., Cong, X., Xiao, N., Liu, Y. C., Kotenko, S. V., Ellies, L. G., and Zhang, D. E. (2013) Usp18 deficient mammary epithelial cells create an antitumour environment driven by hypersensitivity to IFN-λ and elevated secretion of Cxcl10. EMBO Mol. Med. 5, 1035-1050
28. Dellgren, C., Gad, H. H., Hamming, O. J., Melchjorsen, J., and Hartmann, R. (2009) Human interferon-λ3 is a potent member of the type III interferon family. Genes Immun. 10, 125-131
29. Hamming, O. J., Terczyńska-Dyla, E., Vieyres, G., Dijkman, R., Jørgensen, S. E., Akhtar, H., Siupka, P., Pietschmann, T., Thiel, V., and Hartmann, R. (2013) Interferon λ4 signals via the IFNλ receptor to regulate antiviral activity against HCV and coronaviruses. EMBO J. 32, 3055-3065
30. Donnelly, R. P., and Kotenko, S. V. (2010) Interferon-λ: a new addition to an old family. J. Interferon Cytokine Res. 30, 555-564
31. Iversen, M. B., and Paludan, S. R. (2010) Mechanisms of type III interferon expression. J. Interferon Cytokine Res. 30, 573-578
32. Nakagawa, S., Hirata, Y., Kameyama, T., Tokunaga, Y., Nishito, Y., Hirabayashi, K., Yano, J., Ochiya, T., Tateno, C., Tanaka, Y., Mizokami, M., Tsukiyama-Kohara, K., Inoue, K., Yoshiba, M., Takaoka, A., and Kohara, M. (2013) Targeted induction of interferon-λ in humanized chimeric mouse liver abrogates hepatotropic virus infection. PLoS ONE 8, e59611
33. Jewell, N. A., Cline, T., Mertz, S. E., Smirnov, S. V., Flaño, E., Schindler, C., Grieves, J. L., Durbin, R. K., Kotenko, S. V., and Durbin, J. E. (2010) λ interferon is the predominant interferon induced by influenza A virus infection in vivo. J. Virol. 84, 11515-11522
34. Sato, S., Li, K., Kameyama, T., Hayashi, T., Ishida, Y., Murakami, S., Watanabe, T., Iijima, S., Sakurai, Y., Watashi, K., Tsutsumi, S., Sato, Y., Akita, H., Wakita, T., Rice, C. M., et al. (2015) The RNA sensor RIG-I dually functions as an innate sensor and direct antiviral factor for hepatitis B virus. Immunity 42, 123-132
35. Mahlakõiv, T., Hernandez, P., Gronke, K., Diefenbach, A., and Staeheli, P. (2015) Leukocyte-derived IFN-α/β and epithelial IFN-λ constitute a compartmentalized mucosal defense system that restricts enteric virus infections. PLoS Pathog. 11, e1004782
36. Thomas, E., Gonzalez, V. D., Li, Q., Modi, A. A., Chen, W., Noureddin, M., Rotman, Y., and Liang, T. J. (2012) HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons. Gastroenterology 142, 978-988
37. Wang, J., Oberley-Deegan, R., Wang, S., Nikrad, M., Funk, C. J., Hartshorn, K. L., and Mason, R. J. (2009) Differentiated human alveolar type II cells secrete antiviral IL-29 (IFN-λ1) in response to influenzaAinfection. J. Immunol. 182, 1296-1304
38. Marukian, S., Andrus, L., Sheahan, T. P., Jones, C. T., Charles, E. D., Ploss, A., Rice, C. M., and Dustin, L. B. (2011) Hepatitis C virus induces interferon-λ and interferon-stimulated genes in primary liver cultures. Hepatology 54, 1913-1923
39. Okabayashi, T., Kojima, T., Masaki, T., Yokota, S., Imaizumi, T., Tsutsumi, H., Himi, T., Fujii, N., and Sawada, N. (2011) Type-III interferon, not type-I, is the predominant interferon induced by respiratory viruses in nasal epithelial cells. Virus Res. 160, 360-366
40. Khaitov, M. R., Laza-Stanca, V., Edwards, M. R., Walton, R. P., Rohde, G., Contoli, M., Papi, A., Stanciu, L. A., Kotenko, S. V., and Johnston, S. L. (2009) Respiratory virus induction of α-, β-and λ-interferons in bronchial epithelial cells and peripheral blood mononuclear cells. Allergy 64, 375-386
41. Lin, J. D., Feng, N., Sen, A., Balan, M., Tseng, H. C., McElrath, C., Smirnov, S. V., Peng, J., Yasukawa, L. L., Durbin, R. K., Durbin, J. E., Greenberg, H. B., and Kotenko, S. V. (2016) Distinct roles of type I and type III interferons in intestinal immunity to homologous and heterologous rotavirus infections. PLoS Pathog. 12, e1005600
42. Megjugorac, N. J., Gallagher, G. E., and Gallagher, G. (2010) IL-4 enhances IFN-λ1 (IL-29) production by plasmacytoid DCs via monocyte secretion of IL-1Ra. Blood 115, 4185-4190
43. Yin, Z., Dai, J., Deng, J., Sheikh, F., Natalia, M., Shih, T., Lewis-Antes, A., Amrute, S. B., Garrigues, U., Doyle, S., Donnelly, R. P., Kotenko, S. V., and Fitzgerald-Bocarsly, P. (2012) Type III IFNs are produced by and stimulate human plasmacytoid dendritic cells. J. Immunol. 189, 2735-2745
44. Coccia, E. M., Severa, M., Giacomini, E., Monneron, D., Remoli, M. E., Julkunen, I., Cella, M., Lande, R., and Uzé, G. (2004) Viral infection and Toll-like receptor agonists induce a differential expression of type I and λ interferons in human plasmacytoid and monocyte-derived dendritic cells. Eur. J. Immunol. 34, 796-805
45. Yoshio, S., Kanto, T., Kuroda, S., Matsubara, T., Higashitani, K., Kakita, N., Ishida, H., Hiramatsu, N., Nagano, H., Sugiyama, M., Murata, K., Fukuhara, T., Matsuura, Y., Hayashi, N., Mizokami, M., and Takehara, T. (2013) Human blood dendritic cell antigen 3 (BDCA3) dendritic cells are a potent producer of interferon-λ in response to hepatitis C virus. Hepatology 57, 1705-1715
46. Zhang, S., Kodys, K., Li, K., and Szabo, G. (2013) Human type 2 myeloid dendritic cells produce interferon-λ and amplify interferon-α in response to hepatitis C virus infection. Gastroenterology 144, 414-425
47. Lauterbach, H., Bathke, B., Gilles, S., Traidl-Hoffmann, C., Luber, C. A., Fejer, G., Freudenberg, M. A., Davey, G. M., Vremec, D., Kallies, A., Wu, L., Shortman, K., Chaplin, P., Suter, M., O'Keeffe, M., and Hochrein, H. (2010) Mouse CD8α+ DCs and human BDCA3+ DCs are major producers of IFN-λ in response to poly IC. J. Exp. Med. 207, 2703-2717
48. Hoffmann, H. H., Schneider, W. M., and Rice, C. M. (2015) Interferons and viruses: an evolutionary arms race of molecular interactions. Trends Immunol. 36, 124-138
49. Lee, H. C., Narayanan, S., Park, S. J., Seong, S. Y., and Hahn, Y. S. (2014) Transcriptional regulation of IFN-λ genes in hepatitis C virus-infected hepatocytes via IRF-3.IRF-7.NF-κB complex. J. Biol. Chem. 289, 5310-5319
50. Iversen, M. B., Ank, N., Melchjorsen, J., and Paludan, S. R. (2010) Expression of type III interferon (IFN) in the vaginal mucosa is mediated primarily by dendritic cells and displays stronger dependence on NF-κB than type I IFNs. J. Virol. 84, 4579-4586
51. Thomson, S. J., Goh, F. G., Banks, H., Krausgruber, T., Kotenko, S. V., Foxwell, B. M., and Udalova, I. A. (2009) The role of transposable elements in the regulation of IFN-λ1 gene expression. Proc. Natl. Acad. Sci. U.S.A. 106, 11564-11569
52. Dixit, E., Boulant, S., Zhang, Y., Lee, A. S., Odendall, C., Shum, B., Hacohen, N., Chen, Z. J., Whelan, S. P., Fransen, M., Nibert, M. L., Superti-Furga, G., and Kagan, J. C. (2010) Peroxisomes are signaling platforms for antiviral innate immunity. Cell 141, 668-681
53. Lebreton, A., Lakisic, G., Job, V., Fritsch, L., Tham, T. N., Camejo, A., Matteï, P. J., Regnault, B., Nahori, M. A., Cabanes, D., Gautreau, A., Ait-Si-Ali, S., Dessen, A., Cossart, P., and Bierne, H. (2011) A bacterial protein targets the BAHD1 chromatin complex to stimulate type III interferon response. Science 331, 1319-1321
54. Bierne, H., Travier, L., Mahlakõiv, T., Tailleux, L., Subtil, A., Lebreton, A., Paliwal, A., Gicquel, B., Staeheli, P., Lecuit, M., and Cossart, P. (2012) Activation of type III interferon genes by pathogenic bacteria in infected epithelial cells and mouse placenta. PLoS ONE 7, e39080
55. Ank, N., West, H., Bartholdy, C., Eriksson, K., Thomsen, A. R., and Paludan, S. R. (2006) λ interferon (IFN-λ), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo. J. Virol. 80, 4501-4509
56. Melchjorsen, J., Sirén, J., Julkunen, I., Paludan, S. R., and Matikainen, S. (2006) Induction of cytokine expression by herpes simplex virus in human monocyte-derived macrophages and dendritic cells is dependent on virus replication and is counteracted by ICP27 targeting NF-κB and IRF-3. J. Gen. Virol. 87, 1099-1108
57. Sirén, J., Pirhonen, J., Julkunen, I., and Matikainen, S. (2005) IFN-λ regulates TLR-dependent gene expression of IFN-λ, IFN-λ, IL-28, and IL-29. J. Immunol. 174, 1932-1937
58. Osterlund, P., Veckman, V., Sirén, J., Klucher, K. M., Hiscott, J., Matikainen, S., and Julkunen, I. (2005) Gene expression and antiviral activity of α/β interferons and interleukin-29 in virus-infected human myeloid dendritic cells. J. Virol. 79, 9608-9617
59. Ank, N., Iversen, M. B., Bartholdy, C., Staeheli, P., Hartmann, R., Jensen, U. B., Dagnaes-Hansen, F., Thomsen, A. R., Chen, Z., Haugen, H., Klucher, K., and Paludan, S. R. (2008) An important role for type III interferon (IFN-λ/IL-28) in TLR-induced antiviral activity. J. Immunol. 180, 2474-2485
60. Wack, A., Terczyńska-Dyla, E., and Hartmann, R. (2015) Guarding the frontiers: the biology of type III interferons. Nat. Immunol. 16, 802-809
61. Lazear, H. M., Nice, T. J., and Diamond, M. S. (2015) Interferon-λ: immune functions at barrier surfaces and beyond. Immunity 43, 15-28
62. Heim, M. H., Bochud, P. Y., and George, J. (2016) Host-hepatitis C viral interactions: the role of genetics. J. Hepatol. 65, S22-32
63. Terczyńska-Dyla, E., Bibert, S., Duong, F. H., Krol, I., Jørgensen, S., Collinet, E., Kutalik, Z., Aubert, V., Cerny, A., Kaiser, L., Malinverni, R., Mangia, A., Moradpour, D., Müllhaupt, B., Negro, F., et al. (2014) Reduced IFNλ4 activity is associated with improvedHCVclearance and reduced expression of interferon-stimulated genes. Nat. Commun. 5, 5699
64. Friborg, J., Ross-Macdonald, P., Cao, J., Willard, R., Lin, B., Eggers, B., and McPhee, F. (2015) Impairment of type I but not type III IFN signaling by hepatitis C virus infection influences antiviral responses in primary human hepatocytes. PLoS ONE 10, e0121734
65. Chandra, P. K., Bao, L., Song, K., Aboulnasr, F. M., Baker, D. P., Shores, N., Wimley, W. C., Liu, S., Hagedorn, C. H., Fuchs, S. Y., Wu, T., Balart, L. A., and Dash, S. (2014)HCVinfection selectively impairs type I but not type III IFN signaling. Am. J. Pathol. 184, 214-229
66. Amanzada, A., Kopp, W., Spengler, U., Ramadori, G., and Mihm, S. (2013) Interferon-λ4 (IFNL4) transcript expression in human liver tissue samples. PLoS ONE 8, e84026
67. Paquin, A., Onabajo, O. O., Tang, W., and Prokunina-Olsson, L. (2016) Comparative functional analysis of 12 mammalian IFN-λ4 orthologs. J. Interferon Cytokine Res. 36, 30-36
68. Misumi, I., and Whitmire, J. K. (2014) IFN-λ exerts opposing effects on T cell responses depending on the chronicity of the virus infection. J. Immunol. 192, 3596-3606
69. Dickensheets, H., Sheikh, F., Park, O., Gao, B., and Donnelly, R. P. (2013) Interferon-λ (IFN-λ) induces signal transduction and gene expression in human hepatocytes, but not in lymphocytes or monocytes. J. Leukocyte Biol. 93, 377-385
70. Muir, A. J., Arora, S., Everson, G., Flisiak, R., George, J., Ghalib, R., Gordon, S. C., Gray, T., Greenbloom, S., Hassanein, T., Hillson, J., Horga, M. A., Jacobson, I. M., Jeffers, L., Kowdley, K. V., et al. (2014) A randomized phase 2b study of peginterferon λ-1a for the treatment of chronic HCV infection. J. Hepatol. 61, 1238-1246
71. Doyle, S. E., Schreckhise, H., Khuu-Duong, K., Henderson, K., Rosler, R., Storey, H., Yao, L., Liu, H., Barahmand-pour, F., Sivakumar, P., Chan, C., Birks, C., Foster, D., Clegg, C. H., Wietzke-Braun, P., Mihm, S., and Klucher, K. M. (2006) Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes. Hepatology 44, 896-906
72. Duong, F. H., Trincucci, G., Boldanova, T., Calabrese, D., Campana, B., Krol, I., Durand, S. C., Heydmann, L., Zeisel, M. B., Baumert, T. F., and Heim, M. H. (2014) IFN-λ receptor 1 expression is induced in chronic hepatitis C and correlates with the IFN-λ3 genotype and with nonresponsiveness to IFN-λ therapies. J. Exp. Med. 211, 857-868
73. Mordstein, M., Neugebauer, E., Ditt, V., Jessen, B., Rieger, T., Falcone, V., Sorgeloos, F., Ehl, S., Mayer, D., Kochs, G., Schwemmle, M., Günther, S., Drosten, C., Michiels, T., and Staeheli, P. (2010) λ interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections. J. Virol. 84, 5670-5677
74. Sommereyns, C., Paul, S., Staeheli, P., and Michiels, T. (2008) IFN-λ (IFN-λ) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo. PLoS Pathog. 4, e1000017
75. Pulverer, J. E., Rand, U., Lienenklaus, S., Kugel, D., Zietara, N., Kochs, G., Naumann, R., Weiss, S., Staeheli, P., Hauser, H., and Köster, M. (2010) Temporal and spatial resolution of type I and III IFN responses in vivo. J. Virol. 84, 8626-8638
76. Pott, J., Mahlakõiv, T., Mordstein, M., Duerr, C. U., Michiels, T., Stockinger, S., Staeheli, P., and Hornef, M. W. (2011) IFN-λ determines the intestinal epithelial antiviral host defense. Proc. Natl. Acad. Sci. U.S.A. 108, 7944-7949
77. Nice, T. J., Baldridge, M. T., McCune, B. T., Norman, J. M., Lazear, H. M., Artyomov, M., Diamond, M. S., and Virgin, H. W. (2015) Interferon-λ cures persistent murine norovirus infection in the absence of adaptive immunity. Science 347, 269-273
78. Baldridge, M. T., Nice, T. J., McCune, B. T., Yokoyama, C. C., Kambal, A., Wheadon, M., Diamond, M. S., Ivanova, Y., Artyomov, M., and Virgin, H. W. (2015) Commensal microbes and interferon-λ determine persistence of enteric murine norovirus infection. Science 347, 266-269
79. Lazear, H. M., Daniels, B. P., Pinto, A. K., Huang, A. C., Vick, S. C., Doyle, S. E., Gale, M., Jr., Klein, R. S., and Diamond, M. S. (2015) Interferon-λ restricts West Nile virus neuroinvasion by tightening the blood-brain barrier. Sci. Transl. Med. 7, 284ra259
80. Rauch, I., Rosebrock, F., Hainzl, E., Heider, S., Majoros, A., Wienerroither, S., Strobl, B., Stockinger, S., Kenner, L., Müller, M., and Decker, T. (2015) Noncanonical effects of IRF9 in intestinal inflammation: more than type I and type III interferons. Mol. Cell. Biol. 35, 2332-2343
81. Mordstein, M., Kochs, G., Dumoutier, L., Renauld, J. C., Paludan, S. R., Klucher, K., and Staeheli, P. (2008) Interferon-λ contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses. PLoS Pathog. 4, e1000151
82. Mahlakõiv, T., Ritz, D., Mordstein, M., DeDiego, M. L., Enjuanes, L., Müller, M. A., Drosten, C., and Staeheli, P. (2012) Combined action of type I and type III interferon restricts initial replication of severe acute respiratory syndrome coronavirus in the lung but fails to inhibit systemic virus spread. J. Gen. Virol. 93, 2601-2605
83. Crotta, S., Davidson, S., Mahlakoiv, T., Desmet, C. J., Buckwalter, M. R., Albert, M. L., Staeheli, P., and Wack, A. (2013) Type I and type III interferons drive redundant amplification loops to induce a transcriptional signature in influenza-infected airway epithelia. PLoS Pathog. 9, e1003773
84. Klinkhammer, J. S., D., Schwanderlapp, M;, Mahlakoiv, T., and Staeheli, P. (2016) Interferon-λ controls the spread of influenza viruses from the upper respiratory tract to the lungs and restricts virus transmission in mice. Cytokine 76, 74
85. Kelly, A., Robinson, M. W., Roche, G., Biron, C. A., O'Farrelly, C., and Ryan, E. J. (2016) Immune cell profiling of IFN-λ response shows pDCs express highest level of IFN-λR1 and are directly responsive via the JAKSTAT pathway. J. Interferon Cytokine Res. 36, 671-680
86. Souza-Fonseca-Guimaraes, F., Young, A., Mittal, D., Martinet, L., Bruedigam, C., Takeda, K., Andoniou, C. E., Degli-Esposti, M. A., Hill, G. R., and Smyth, M. J. (2015) NK cells require IL-28R for optimal in vivo activity. Proc. Natl. Acad. Sci. U.S.A. 112, E2376-2384
87. Abushahba, W., Balan, M., Castaneda, I., Yuan, Y., Reuhl, K., Raveche, E., de la Torre, A., Lasfar, A., and Kotenko, S. V. (2010) Antitumor activity of type I and type III interferons in BNL hepatoma model. Cancer Immunol. Immunother. 59, 1059-1071
88. Lasfar, A., de laTorre, A., Abushahba, W., Cohen-Solal, K. A., Castaneda, I., Yuan, Y., Reuhl, K., Zloza, A., Raveche, E., Laskin, D. L., and Kotenko, S. V. (2016) Concerted action of IFN-λ and IFN-λ induces local NK cell immunity and halts cancer growth. Oncotarget 7, 49259-49267
89. de Groen, R. A., Boltjes, A., Hou, J., Liu, B. S., McPhee, F., Friborg, J., Janssen, H. L., and Boonstra, A. (2015) IFN-λ-mediated IL-12 production in macrophages induces IFN-λ production in humanNKcells. Eur. J. Immunol. 45, 250-259
90. Morrison, M. H., Keane, C., Quinn, L. M., Kelly, A., O'Farrelly, C., Bergin, C., and Gardiner, C. M. (2014) IFNL cytokines do not modulate human or murine NK cell functions. Hum. Immunol. 75, 996-1000
91. Blazek, K., Eames, H. L., Weiss, M., Byrne, A. J., Perocheau, D., Pease, J. E., Doyle, S., McCann, F., Williams, R. O., and Udalova, I. A. (2015) IFN-λ resolves inflammation via suppression of neutrophil infiltration and IL-1λ production. J. Exp. Med. 212, 845-853
92. Megjugorac, N. J., Gallagher, G. E., and Gallagher, G. (2009) Modulation of human plasmacytoidDCfunction by IFN-λ1 (IL-29). J. Leukocyte Biol. 86, 1359-1363
93. Mennechet, F. J., and Uzé, G. (2006) Interferon-λ-treated dendritic cells specifically induce proliferation of FOXP3-expressing suppressor T cells. Blood 107, 4417-4423
94. Koltsida, O., Hausding, M., Stavropoulos, A., Koch, S., Tzelepis, G., Ubel, C., Kotenko, S. V., Sideras, P., Lehr, H. A., Tepe, M., Klucher, K. M., Doyle, S. E., Neurath, M. F., Finotto, S., and Andreakos, E. (2011) IL-28A (IFN-λ2) modulates lung DC function to promote Th1 immune skewing and suppress allergic airway disease. EMBO Mol. Med. 3, 348-361
95. Davidson, S., Crotta, S., McCabe, T. M., and Wack, A. (2014) Pathogenic potential of interferon αβ in acute influenza infection. Nat. Commun. 5, 3864
96. Davidson, S., McCabe, T. M., Crotta, S., Gad, H. H., Hessel, E. M., Beinke, S., Hartmann, R., and Wack, A. (2016) IFNλ is a potent anti-influenza therapeutic without the inflammatory side effects of IFNα treatment. EMBO Mol. Med. 8, 1099-1112
97. Dumoutier, L., Tounsi, A., Michiels, T., Sommereyns, C., Kotenko, S. V., and Renauld, J. C. (2004) Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-λ1: similarities with type I interferon signaling. J. Biol. Chem. 279, 32269-32274
98. Schoggins, J. W., and Rice, C. M. (2011) Interferon-stimulated genes and their antiviral effector functions. Curr. Opin. Virol. 1, 519-525
99. Brand, S., Zitzmann, K., Dambacher, J., Beigel, F., Olszak, T., Vlotides, G., Eichhorst, S. T., Göke, B., Diepolder, H., and Auernhammer, C. J. (2005) SOCS-1 inhibits expression of the antiviral proteins 2′,5′-OAS and MxA induced by the novel interferon-λs IL-28A and IL-29. Biochem. Biophys. Res. Commun. 331, 543-548
100. Zhang, X., Brann, T. W., Zhou, M., Yang, J., Oguariri, R. M., Lidie, K. B., Imamichi, H., Huang, D. W., Lempicki, R. A., Baseler, M. W., Veenstra, T. D., Young, H. A., Lane, H. C., and Imamichi, T. (2011) Cutting edge: Ku70 is a novel cytosolic DNA sensor that induces type III rather than type I IFN. J. Immunol. 186, 4541-4545
101. Swamy, M., Abeler-Dörner, L., Chettle, J., Mahlakõiv, T., Goubau, D., Chakravarty, P., Ramsay, G., Reis e Sousa, C., Staeheli, P., Blacklaws, B. A., Heeney, J. L., and Hayday, A. C. (2015) Intestinal intraepithelial lymphocyte activation promotes innate antiviral resistance. Nat. Commun. 6, 7090